Abstract:In the continuous combat against diseases, there is the need for tools that enable an improved diagnostic efficiency towards higher information density combined with reduced time-to-result and cost. Here, a novel fully integrated microfluidic platform, the Evalution™, is evaluated as a potential solution to this need. Encoded microparticles combined with channel-based microfluidics allow a fast, sensitive and simultaneous detection of several disease-related biomarkers. Since the binary code is represented by physically present holes, 210 different codes can be created that will not be altered by light or chemically induced degradation. Exploiting the unique features of this multiplex platform, hybridization chain reaction (HCR) is explored as a generic approach to reach the desired sensitivity. Compared to a non-amplified reference system, the sensitivity was drastically improved by a factor of 104, down to low fM LOD values. Depending on the HCR duration, the assay can be tuned for sensitivity or total assay time, as desired. The huge potential of this strategy was further demonstrated by the successful detection of a multiplex panel of six different nucleic acid targets including viruses and bacteria. The ability to not only discriminate these two categories but, with the same effort, also virus strains (human adenovirus and human bocavirus), virus subtypes (human adenovirus type B and D) and antibiotic-resistant bacteria (Streptococcus pneumonia), exemplifies the specificity of the developed approach. The effective, yet highly simplified, isothermal and protein-enzyme-free signal amplification tool reaches an LOD ranging from as low as 33 ± 4 to 151 ± 12 fM for the different targets. Moreover, direct detection in a clinically relevant sample matrix was verified, resulting in a detection limit of 309 ± 80 fM, approximating the low fM levels detectable with the gold standard analysis method, PCR, without the drawbacks related to protein enzymes, thermal cycling and elaborate sample preparation steps. The reported strategy can be directly transferred as a generic approach for the sensitive and specific detection of various target molecules in multiplex. In combination with the high-throughput capacity and reduced reagent consumption, the Evalution™ demonstrates immense potential in the next generation of diagnostic tools towards more personalized medicine.

Ultra-sensitive and rapid detection of nucleic acids and microorganisms in body fluids using single-molecule tethering

Single-molecule immunoassay technology: Recent advances

Integrated Microfluidic Systems with Sample Preparation and Nucleic Acid Amplification.

Highly Sensitive Multiplex Detection of Molecular Biomarkers Using Hybridization Chain Reaction in an Encoded Particle Microfluidic Platform

Ultrasensitive detection of SARS-CoV-2 RNA and antigen using single-molecule optofluidic chip

Sensing Single Molecule under Micromanipulation to Quantify Nucleic Acids

Dynamic single-molecule sensing by actively tuning binding kinetics for ultrasensitive biomarker detection

Molecular-electromechanical system for unamplified detection of trace analytes in biofluids

Ultrasensitive, Multiplexed Buoyant Sensor for Monitoring Cytokines in Biofluids

Droplet Digital Molecular Beacon-Lamp Assay Via Pico-Injection for Ultrasensitive Detection of Pathogens.

Direct capture and amplification of nucleic acids using a universal, elution-free magnetic bead-based method for rapid pathogen detection in multiple types of biological samples

Ultrasensitive Hybridization Chain Reaction-Assisted Multisite Exonuclease III Amplification Strategy Combined with a Direct Quantitative Fluorescence Lateral Flow Technique for Multiple Bacterial 16S rRNA Detection

Fast infectious diseases diagnostics based on microfluidic biochip system

Utpcr: A Strategy for the Highly Specific and Absolutely Quantitative Detection of Single Molecules Within Only Minutes.

A pocket-sized device automates multiplexed point-of-care RNA testing for rapid screening of infectious pathogens

Bimetallic interface on an optical microfiber nucleic acid sensor: Early detection in body fluids

Label-free single-particle imaging approach for ultra-rapid detection of pathogenic bacteria in clinical samples

Simultaneous Detection of Multiple Respiratory Pathogens Using an Integrated Microfluidic Chip

Rapid Detection of Uropathogens Using an Integrated Multiplex Digital Nucleic Acid Detection Assay Powered by a Digital-to-Droplet Microfluidic Device

Rapid Identification and Monitoring of Multiple Bacterial Infections Using Printed Nanoarrays

Super-assembly of Integrated Gold Magnetic Assay with Loop-Mediated Isothermal Amplification for Point-of-care Testing.